title: Peritoneal dialysis in developing countries.
abstract: Peritoneal dialysis (PD) is acknowledged worldwide as a well-accepted form of renal replacement therapy (RRT) for end-stage renal disease (ESRD). Ideally, PD should be the preferred modality of RRT for ESRD in developing countries due to its many inherent advantages. Some of these are cost savings (especially if PD fluids are manufactured locally or in a neighboring country), superior rehabilitation and quality of life (QOL), home-based therapy even in rural settings, avoidance of hospital based treatment and the need for expensive machinery, and freedom from serious infections (hepatitis B and C). However, this is not the ground reality, due to certain preconceived notions of the health care givers and governmental agencies in these countries. With an inexplicable stagnation or decline of PD numbers in the developed world, the future of PD will depend on its popularization in Latin America and in Asia especially countries such as China and India, with a combined population of 2.5 billion and the two fastest growing economies worldwide. A holistic approach to tackle the issues in the developing countries, which may vary from region to region, is critical in popularizing PD and establishing PD as the first-choice RRT for ESRD. At our center, we have been pursuing a 'PD first' policy and promoting PD as the therapy of choice for various situations in the management of renal failure. We use certain novel strategies, which we hope can help PD centers in other developing countries working under similar constraints. The success of a PD program depends on a multitude of factors that are interlinked and inseparable. Each program needs to identify its strengths, special circumstances, and deficiencies, and then to strategize accordingly. Ultimately, teamwork is the 'mantra' for a successful outcome, the patient being central to all endeavors. A belief and a passion for PD are the fountainhead and cornerstone on which to build a quality PD program.
authors.forename: K S
authors.initials: KS
authors.lastname: Nayak
authors.forename: M V
authors.initials: MV
authors.lastname: Prabhu
authors.forename: K A
authors.initials: KA
authors.lastname: Sinoj
authors.forename: S V
authors.initials: SV
authors.lastname: Subhramanyam
authors.forename: G
authors.initials: G
authors.lastname: Sridhar
mesh_terms: D000349:Africa; D001208:Asia; D003906:Developing Countries; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D007843:Latin America; D010530:Peritoneal Dialysis / Q000191:economics / Q000639:trends*; D006435:Renal Dialysis / Q000191:economics; D017582:Renal Replacement Therapy; D016896:Treatment Outcome